SAN FRANCISCO, Aug. 12 - Applied Biosystems' next-generation sequencer, scheduled for commercial introduction on Wednesday, is in the hands of early-access partners. So far they're impressed. The next challenge for ABI is to sell the tools in a receding sequencing market.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.